MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Key Account Manager (KAM)contributes to Mirum’s mission by helping improve awareness, access and support for patients living with rare liver diseases across the assigned region in Germany. This is a field-based commercial professional responsible for developing and growing Mirum’s hepatology disease portfolio within an assigned territory in Germany.
While working in close partnership with healthcare professionals and multidisciplinary care teams, the KAM develops and executes strategic account plans for priority centers and regional networks that support appropriate patient identification, access and use of Mirum’s therapies. The KAM combines strong clinical knowledge with commercial excellence to build trusted customer relationships, identify opportunities and support long-term account development. These roles work collaboratively with Medical Affairs, Market Access, Marketing and other cross-functional partners and translates customer insights into effective account strategies while ensuring all activities comply with applicable legal, regulatory and company requirements.
KEY RESPONSIBILITIES
- Develop and execute strategic account plans for priority centers and regional networks aligned with national commercial objectives
- Build trusted partnerships with healthcare professionals, KOLs, specialist centers, academic hospitals and multidisciplinary care teams across the assigned region
- Deliver high-quality scientific and product discussions that support appropriate patient care
- Identify customer needs and align Mirum resources and solutions to support appropriate patient care
- Continuously assess regional account opportunities using customer insights, market intelligence and business data
- Support account-readiness activities by identifying awareness, diagnostic pathway and referral-process gaps within priority accounts and regional networks
- Share compliant field insights to support market development, account readiness and future launch planning
- Collaborate effectively with Medical Affairs, Market Access, Marketing and other cross-functional colleagues
- Maintain strong knowledge of relevant disease states, treatment landscape and Mirum’s products
- Demonstrate accountability for territory performance while consistently operating in compliance with company policies and applicable regulations
- Contribute positively to a collaborative Mirum culture by sharing best practices and supporting team success
QUALIFICATIONS & REQUIREMENTS
- Bachelor’s degree in science or related field required; advanced degree preferred
- 3+ years of professional experience in pharmaceutical or biotech field-based commercial roles
- Proven track record in delivering results in specialty care or rare disease markets
- Demonstrated success supporting product launch, growth or market-development activities in complex healthcare environments
- Experience in liver disease, rare disease, GI, hepatology or related specialty areas preferred
- Understanding of strategic account management, regional healthcare structures and the German healthcare environment
- Commitment to compliance, ethical business practices and appropriate scientific exchange
- Willingness to travel frequently, including overnight travel
- Fluency in German and English, with the ability to read, understand and communicate scientific and business information in English
KEY COMPETENCIES
- Patient-centric mindset and commitment to improving outcomes for people living with rare diseases
- Strong strategic account thinking, prioritization and follow-through skills
- Effective influencing, stakeholder management and relationship-building skills
- Accountability, resilience and growth mindset
- Strong clinical acumen and commitment to continuous learning
#LI-REMOTE
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Skills Required
- Bachelor's degree in science or related field
- Advanced degree
- 3+ years of professional experience in pharmaceutical or biotech field-based commercial roles
- Proven track record in delivering results in specialty care or rare disease markets
- Demonstrated success supporting product launch, growth or market-development activities
- Experience in liver disease, rare disease, GI, hepatology or related specialty areas
- Understanding of strategic account management, regional healthcare structures and the German healthcare environment
- Commitment to compliance, ethical business practices and appropriate scientific exchange
- Willingness to travel frequently, including overnight travel
- Fluency in German and English, ability to read, understand and communicate scientific and business information in English
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
.png)
